Drugs / 131 I-lipiodol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00116454 | Jul 2005 → Aug 2013 | hepatocellular carcinoma, viral hepatitis | ANRS, Emerging Infectious Diseases | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 131 I-lipiodol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00116454 ↗ |